Narendra Modi gets second dose of Covid vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 22, 2022
SUNDAY, MAY 22, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Narendra Modi gets second dose of Covid vaccine

Coronavirus chronicle

UNB
08 April, 2021, 11:25 am
Last modified: 08 April, 2021, 02:18 pm

Related News

  • Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
  • Biden to Modi: Buying more Russian oil is not in India's interest
  • Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety
  • WHO suspends Covaxin supplies under UN procurement
  • US sends senior national security official to India to discuss Ukraine

Narendra Modi gets second dose of Covid vaccine

Modi took the first shot of the 'Made in India' Covaxin vaccine developed by Bharat Biotech on March 1

UNB
08 April, 2021, 11:25 am
Last modified: 08 April, 2021, 02:18 pm
Addressing a petroleum university’s convocation, Modi said: “Work is being done to nearly double the country’s oil refining capacity in the next five years” Photo: Collected from Twitter
Addressing a petroleum university’s convocation, Modi said: “Work is being done to nearly double the country’s oil refining capacity in the next five years” Photo: Collected from Twitter

Indian Prime Minister Narendra Modi received his second dose of the Covid-19 vaccine at the premier All India Institute of Medical Sciences in Delhi on Thursday morning.

Got my second dose of the COVID-19 vaccine at AIIMS today.

Vaccination is among the few ways we have, to defeat the virus.

If you are eligible for the vaccine, get your shot soon. Register on https://t.co/hXdLpmaYSP. pic.twitter.com/XZzv6ULdan— Narendra Modi (@narendramodi) April 8, 2021

Modi took the first shot of the 'Made in India' Covaxin vaccine developed by Bharat Biotech on March 1.

Allaying concerns about the safety of the jabs, the Indian PM urged all eligible people to get the Covid vaccine at the earliest in order "to defeat the virus".

"Got my second dose of the Covid-19 vaccine at AIIMS today. Vaccination is among the few ways we have, to defeat the virus. If you are eligible for the vaccine, get your shot soon," the Indian PM tweeted, soon after receiving the jab.

India has been witnessing a massive surge in coronavirus infections over the past few weeks. On Thursday, India reported over 1.26 lakh new cases in 24 hours. The total caseload now stands at over 1.66 crore.

Covaxin and Covishield, developed by the Serum Institute of India (SII) in collaboration with Oxford University and AstraZeneca, are being used in the country's vaccination drive that began on January 16 this year.

At the launch of the world's largest Covid-19 vaccination programme in January, which aims at eventually inoculating India's 1.3 billion people against coronavirus, Modi urged citizens not to pay heed to rumours regarding the safety of the vaccines. 

"The Drug Controller General of India gave approval after they were satisfied with the data of the two vaccines. So stay away from rumours. Our vaccine developers have a global credibility. They will give a decisive victory to our country," he had said.

Top News / World+Biz

Indian PM Narendra Modi / vaccinated / Bharat Biotech / Bharat Biotech Covid-19 vaccine / COVAXIN

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Project delays: The Sinohydro style 
    Project delays: The Sinohydro style 
  • Photo: TBS
    37,000 BO account holders sell all shares in 11 days
  • Photo: Reuters
    Monkeypox: Govt puts ports on alert 

MOST VIEWED

  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine
  • A man checks phone at Lujiazui financial district in Pudong, Shanghai, China March 14, 2019. Photo :Reuters
    Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • North Korean leader Kim Jong Un delivers opening remarks during the 2nd Conference of Secretaries of Primary Committees of the Workers' Party of Korea (WPK), in this photo released on February 27, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS/File Photo
    N Korea reports over 200,000 fever cases for 5th day amid Covid wave

Related News

  • Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
  • Biden to Modi: Buying more Russian oil is not in India's interest
  • Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety
  • WHO suspends Covaxin supplies under UN procurement
  • US sends senior national security official to India to discuss Ukraine

Features

The Buffalo shooter targeted Black people, linking mass migration with environmental degradation and other eco-fascist ideas. Photo: Reuters

Eco-fascism: The greenwashing of the far right

13h | Panorama
Green-backed Heron on a tilting stalk. Photo: Enam Ul Haque

Green-backed Heron: Nothing but a prayer to catch a fish  

15h | Panorama
Illustration: TBS

‘High logistics cost weakens Bangladesh’s competitiveness’

17h | Panorama
Every morning is a new beginning for all

Seashore

18h | In Focus

More Videos from TBS

Wheat prices double in India

Wheat prices double in India

7h | Videos
Is Washington-Moscow agreement possible?

Is Washington-Moscow agreement possible?

7h | Videos
Pigeon exhibition for the first time in Gazipur

Pigeon exhibition for the first time in Gazipur

11h | Videos
Photo: TBS

US Congress to hold first public UFO panel

13h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam
Habitat

The United House: Living and working inside nature

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab